Trial Profile
Treatment With Liraglutide as add-on to Insulin in Type 1 Diabetic Patients. Effects on Glycemic Control and Counterregulation and Cognitive Performance During Hypoglycaemia
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary) ; Insulin
- Indications Type 1 diabetes mellitus
- Focus Pharmacodynamics; Therapeutic Use
- Acronyms T1DMLIRA
- 16 Sep 2016 Results (n=20) analysing the effect of liraglutide on cerebral electrical activity and cognitive performance, presented at the 52nd Annual Meeting of the European Association for the Study of Diabetes.
- 20 Oct 2015 Primary endpoint has not been met. (Change from baseline in HbA1c (glycosylated haemoglobin)), as per an article published in the Diabetes Care
- 20 Oct 2015 Results published in the Diabetes Care